Skip to main content

Advertisement

Log in

Streptomycetes as platform for biotechnological production processes of drugs

  • Mini-Review
  • Published:
Applied Microbiology and Biotechnology Aims and scope Submit manuscript

Abstract

Streptomyces is one of the most versatile genera for biotechnological applications, widely employed as platform in the production of drugs. Although streptomycetes have a complex life cycle and metabolism that would need multidisciplinary approaches, review papers have generally reported only studies on single aspects like the isolation of new strains and metabolites, morphology investigations, and genetic or metabolic studies. Besides, even if streptomycetes are extensively used in industry, very few review papers have focused their attention on the technical aspects of biotechnological processes of drug production and bioconversion and on the key parameters that have to be set up. This mini-review extensively illustrates the most innovative developments and progresses in biotechnological production and bioconversion processes of antibiotics, immunosuppressant, anticancer, steroidal drugs, and anthelmintic agents by streptomycetes, focusing on the process development aspects, describing the different approaches and technologies used in order to improve the production yields. The influence of nutrients and oxygen on streptomycetes metabolism, new fed-batch fermentation strategies, innovative precursor supplementation approaches, and specific bioreactor design as well as biotechnological strategies coupled with metabolic engineering and genetic tools for strain improvement is described. The use of whole, free, and immobilized cells on unusual supports was also reported for bioconversion processes of drugs. The most outstanding thirty investigations published in the last 8 years are here reported while future trends and perspectives of biotechnological research in the field have been illustrated.

Key points

Updated Streptomyces biotechnological processes for drug production are reported.

Innovative approaches for Streptomyces-based biotransformation of drugs are reviewed.

News about fermentation and genome systems to enhance secondary metabolite production.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+
from $39.99 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

Download references

Funding

This work was financed by Campania Region-POR FESR 2007-2013 B25C13000290007 in the frame of project “Bio industrial processes-BIP.” S.B.F. is enrolled in a PhD program with an industrial project called “Streptomycetes as technological platform for the improvement of biotechnological productive processes of pharmaceutical active principles and/or nutraceuticals of industrial interests.”

Author information

Authors and Affiliations

Authors

Contributions

O.F.R. and S.B.F. conceived, drafted, and wrote the manuscript; C.S. obtained funds and reviewed the manuscript; M.C. performed SEM experiments. All authors read and approved the manuscript.

Corresponding author

Correspondence to Odile Francesca Restaino.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Barbuto Ferraiuolo, S., Cammarota, M., Schiraldi, C. et al. Streptomycetes as platform for biotechnological production processes of drugs. Appl Microbiol Biotechnol 105, 551–568 (2021). https://doi.org/10.1007/s00253-020-11064-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00253-020-11064-2

Keywords